Glucocorticoids (GCs) are best known for their potent anti-inflammatory effects. However, an emerging model for glucocorticoid (GC) regulation of in vivo inflammation also includes a delayed, preparatory effect that manifests as enhanced inflammation following exposure to an inflammatory stimulus. When GCs are transiently elevated in vivo following exposure to a stressful event, this model proposes that a subsequent period of increased inflammatory responsiveness is adaptive because it enhances resistance to a subsequent stressor. In the present study, we examined the migratory response of human monocytes/macrophages following transient in vivo exposure to stress-associated concentrations of cortisol. Participants were administered cortisol for 6 h to elevate in vivo cortisol levels to approximate those observed during major systemic stress. Monocytes in peripheral blood and macrophages in sterile inflammatory tissue (skin blisters) were studied before and after exposure to cortisol or placebo. We found that exposure to cortisol induced transient upregulation of monocyte mRNA for CCR2, the receptor for monocyte chemotactic protein-1 (MCP-1/CCL2) as well as for the chemokine receptor CX3CR1. At the same time, mRNA for the transcription factor IjBa was decreased. Monocyte surface expression of CCR2 but not CX3CR1 increased in the first 24 h after cortisol exposure. Transient exposure to cortisol also led to an increased number of macrophages and neutrophils in fluid derived from a sterile inflammatory site in vivo. These findings suggest that the delayed, pro-inflammatory effects of cortisol on the human inflammatory responses may include enhanced localization of effector cells at sites of in vivo inflammation.
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Introduction
Glucocorticoids (GCs) are widely understood to suppress inflammation through regulation of signaling pathways in leukocytes and other effector cells. Until recently, these potent and clinically important effects of GCs have obscured results from earlier research that demonstrated GC support and even stimulation of in vivo defense mechanisms (Ingle, 1952 ). An emerging model for GC regulation of defense mechanisms includes not only their well-known anti-inflammatory properties but also a teleological conception in which GCs can enhance the in vivo response to external stressors. Evidence for GC enhancement of inflammation was described as early as 1954 by Selye (Selye, 1954) , was re-introduced into the clinical literature in 1984 (Munck et al., 1984) , and has since been expanded by subsequent research (Barber et al., 1993; Yeager et al., 2004; Frank et al., 2009; Sorrells and Sapolsky, 2007; Busillo and Cidlowski, 2013; Kamisoglu et al., 2014; Cruz-Topete and Cidlowski, 2015) . Time is a critical variable. Concurrent exposure of immune effector cells to GCs engenders the two best-known properties of GCs: (1) At low 'basal' concentrations, a 'permissive' GC effect supports other metabolic and inflammatory processes so that they proceed normally (Ingle, 1950; Udelsman et al., 1986) . The absence of this GC activity leads to the Addisonian crisis first described in the 19th century (Addison, 1849). (2) At higher concentrations of GCs, when concurrent with systemic stress, the well-known antiinflammatory effects of GCs are observed and act to prevent damage from an excessive inflammatory response to an imposed stimulus (Munck and Náray-Fejes-Tóth, 1992 
